Browsing Tag

CSIR-IIIM

Anti-COVID Drug ‘Colchicine’ Cleared for Phase 2 Clinical Trials

ISW Desk Jun 18, 2021 0

Council of Scientific & Industrial Research (CSIR), and Laxai Life Sciences Pvt. Ltd., Hyderabad, have been given the regulatory approval by the Drugs Controller General of India (DCGI) to undertake a two-arm phase-II clinical trial to…
Read More...

Our Campaigns

Support & Donate Now

The role of journalism is strongly challenged now more than ever before. It is imperative that the fourth pillar of democracy publish news and views in its most credible form. We at Delhi Post place the highest regard for freedom of expression. We strive to publish the truth and assert credibility over chaos. To safeguard the independent, non-partisan space, we depend on the support of our readers and contributors. Please Donate Now and join us in maintaining this platform which is a voice for every individual with an opinion!